NEW YORK (GenomeWeb News) – Alere said today that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill and Melinda Gates Foundation to further develop a pair of point-of-care molecular testing platforms.

Under the $21.6 million grant, Alere will develop a tuberculosis assay designed for use in both resource-poor and industrialized settings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.